Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux
Sanna N Masud1,2,3, Megha Chandrashekhar1,2,4, Michael Aregger2,5
1Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Abstract:
Pyrvinium is a quinoline-derived cyanine dye and an approved anti-helminthic drug reported to inhibit WNT signaling and have anti-proliferative effects in various cancer cell lines. To further understand the mechanism by which pyrvinium is cytotoxic, we conducted a pooled genome-wide CRISPR loss-of-function screen in the human HAP1 cell model. The top drug-gene sensitizer interactions implicated the malate-aspartate and glycerol-3-phosphate shuttles as mediators of cytotoxicity to mitochondrial complex I inhibition including pyrvinium. By contrast, perturbation of the poorly characterized gene C1orf115/RDD1 resulted in strong resistance to the cytotoxic effects of pyrvinium through dysregulation of the major drug efflux pump ABCB1/MDR1. Interestingly, C1orf115/RDD1 was found to physically associate with ABCB1/MDR1 through proximity-labeling experiments and perturbation of C1orf115 led to mis-localization of ABCB1/MDR1. Our results are consistent with a model whereby C1orf115 modulates drug efflux through regulation of the major drug exporter ABCB1/MDR1.
Insights
Pyrvinium
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Pyrvinium, a quinoline-derived cyanine dye, is an anti-helminthic drug with known anti-proliferative effects in cancer cells.
- Pyrvinium's cytotoxic mechanisms, particularly its inhibition of WNT signaling and mitochondrial complex I, are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying pyrvinium's cytotoxicity.
- To identify genetic factors mediating sensitivity and resistance to pyrvinium treatment.
Main Methods:
- A pooled, genome-wide CRISPR loss-of-function screen was performed in HAP1 cells to identify genes affecting pyrvinium sensitivity.
- Proximity-labeling experiments were used to investigate the physical association between C1orf115/RDD1 and ABCB1/MDR1.
Main Results:
- The malate-aspartate and glycerol-3-phosphate shuttles were identified as mediators of pyrvinium-induced cytotoxicity via mitochondrial complex I inhibition.
- Perturbation of C1orf115/RDD1 conferred resistance to pyrvinium by dysregulating the drug efflux pump ABCB1/MDR1.
- C1orf115/RDD1 physically associates with ABCB1/MDR1 and regulates its localization and function.
Conclusions:
- Pyrvinium's cytotoxicity involves mitochondrial complex I inhibition, modulated by metabolic shuttles.
- C1orf115/RDD1 plays a critical role in pyrvinium resistance by regulating ABCB1/MDR1-mediated drug efflux.
- These findings reveal a novel regulatory mechanism of drug resistance involving C1orf115/RDD1 and ABCB1/MDR1.
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Master Transcription Regulators
Treatment Resistant Cancers
ABC Transporters: Exporter
Regulation of Nuclear Protein Sorting


